19-19624439-A-G
Variant names:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001395660.1(LPAR2):c.864T>C(p.Asn288Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00831 in 1,614,144 control chromosomes in the GnomAD database, including 80 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0076 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0084 ( 73 hom. )
Consequence
LPAR2
NM_001395660.1 synonymous
NM_001395660.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.10
Genes affected
LPAR2 (HGNC:3168): (lysophosphatidic acid receptor 2) This gene encodes a member of family I of the G protein-coupled receptors, as well as the EDG family of proteins. This protein functions as a lysophosphatidic acid (LPA) receptor and contributes to Ca2+ mobilization, a critical cellular response to LPA in cells, through association with Gi and Gq proteins. An alternative splice variant has been described but its full length sequence has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 19-19624439-A-G is Benign according to our data. Variant chr19-19624439-A-G is described in ClinVar as [Benign]. Clinvar id is 788836.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.1 with no splicing effect.
BS2
High AC in GnomAd4 at 1151 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LPAR2 | NM_001395660.1 | c.864T>C | p.Asn288Asn | synonymous_variant | Exon 3 of 3 | ENST00000407877.8 | NP_001382589.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LPAR2 | ENST00000407877.8 | c.864T>C | p.Asn288Asn | synonymous_variant | Exon 3 of 3 | 1 | NM_001395660.1 | ENSP00000384665.3 | ||
LPAR2 | ENST00000542587.5 | c.864T>C | p.Asn288Asn | synonymous_variant | Exon 6 of 6 | 2 | ENSP00000443256.2 | |||
LPAR2 | ENST00000586703.1 | c.864T>C | p.Asn288Asn | synonymous_variant | Exon 3 of 3 | 1 | ENSP00000465280.2 |
Frequencies
GnomAD3 genomes AF: 0.00757 AC: 1152AN: 152182Hom.: 7 Cov.: 32
GnomAD3 genomes
AF:
AC:
1152
AN:
152182
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00821 AC: 2063AN: 251290Hom.: 13 AF XY: 0.00818 AC XY: 1112AN XY: 135870
GnomAD3 exomes
AF:
AC:
2063
AN:
251290
Hom.:
AF XY:
AC XY:
1112
AN XY:
135870
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00839 AC: 12261AN: 1461844Hom.: 73 Cov.: 29 AF XY: 0.00839 AC XY: 6102AN XY: 727212
GnomAD4 exome
AF:
AC:
12261
AN:
1461844
Hom.:
Cov.:
29
AF XY:
AC XY:
6102
AN XY:
727212
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00756 AC: 1151AN: 152300Hom.: 7 Cov.: 32 AF XY: 0.00790 AC XY: 588AN XY: 74472
GnomAD4 genome
AF:
AC:
1151
AN:
152300
Hom.:
Cov.:
32
AF XY:
AC XY:
588
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at